FOXO4-DRI is a synthetic peptide designed to selectively target senescent cells by disrupting the FOXO4-p53 interaction, promoting apoptosis in aged or damaged cells. It is widely used in anti-aging, cellular senescence, and regenerative medicine research, helping to improve tissue function and rejuvenation. How It Works?
FOXO4-DRI works by disrupting the interaction between FOXO4 and p53 in senescent cells:
Blocks FOXO4-p53 binding → induces apoptosis in senescent cells
Clears damaged or aged cells → reduces cellular senescence burden
Promotes regenerative signaling → improves tissue function
Supports anti-aging and longevity research → enhances overall cellular health
Key Features & Benefits
Targets senescent cells for selective apoptosis
Promotes tissue rejuvenation and regenerative capacity
Supports anti-aging research and longevity studies
Enhances cellular repair and homeostasis
Reduces markers of cellular senescence
Highly bioactive peptide suitable for precise research applications
Applications
Cellular senescence and anti-aging studies
Tissue rejuvenation and regenerative medicine research
Longevity and lifespan investigations
Stem cell and cellular repair research
Peptide formulation and therapeutic studies targeting senescence
